All Stories

  1. Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma

    Article • Cancer Control, November 2025, SAGE Publications

    Nabil E. Omar

  2. Global Landscape of the Attack of Predatory Journals in Oncology

    Article • JCO Global Oncology, May 2024, American Society of Clinical Oncology (ASCO)

    Nabil E. Omar

  3. Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

    Article • Clinical Medicine Insights Oncology, January 2024, SAGE Publications

    Nabil E. Omar, Dr Shereen Amin Elazzazy

  4. Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report

    Article • Case Reports in Oncology, August 2023, Karger Publishers

    Nabil E. Omar

  5. Cisplatin-induced ototoxicity: a novel approach to an ancient problem

    Article • Pharmacogenetics and Genomics, April 2023, Wolters Kluwer Health

    Nabil E. Omar

  6. Post‐COVID‐19‐associated multiorgan complications or “long COVID” with literature review and management strategy discussion: A meta‐analysis

    Article • Health Science Reports, April 2023, Wiley

    Nabil E. Omar, Dr Shereen Amin Elazzazy

  7. Tracheoesophageal fistula and esophageal perforation in a patient with advanced gastroesophageal junction tumor post ramucirumab treatment. A case report and literature review

    Article • Current Problems in Cancer Case Reports, March 2023, Elsevier

    Nabil E. Omar

  8. The Financial Toxicity of Advanced Hepatocellular Carcinoma Treatment in Low Middle-Income Countries

    Article • December 2022, MDPI AG

    Nabil E. Omar

  9. Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer

    Article • Clinical Case Reports, October 2022, Wiley

    Nabil E. Omar

  10. COVID-19 Vaccination in Cancer Patients: A Review Article

    Article • Cancer Control, September 2022, SAGE Publications

    Nabil E. Omar

  11. Cardiac Metastases from Choroidal Melanoma

    Article • Clinical Case Reports, July 2022, Wiley

    Nabil E. Omar

  12. Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib

    Article • OncoTargets and Therapy, June 2022, Taylor & Francis

    Nabil E. Omar

  13. Rare case of norethisterone‐induced hepatitis: A case report

    Article • Clinical Case Reports, April 2022, Wiley

    Nabil E. Omar

  14. Stigma towards health care providers taking care of COVID-19 patients: A multi-country study

    Article • Heliyon, April 2022, Elsevier

    Hossam Elamir, Nabil E. Omar, Validity and Reliability of the Arabic Version of the Incivility in Nursing Education-Revised Scale Sabah Abdullah Jaafar

  15. Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)

    Article • ESMO Open, December 2021, Elsevier

    Nabil E. Omar

  16. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia

    Article • PLOS One, August 2021, PLOS

    Nabil E. Omar

  17. Oncotype DX RS Correlation with Clinicopathologic Risk Factors and Chemotherapy: Follow up Based on TAILORx Study

    Article • June 2021, Springer Science + Business Media

    Nabil E. Omar

  18. Invasive ductal breast carcinoma preceded by CALR‐positive essential thrombocythemia

    Article • Clinical Case Reports, February 2021, Wiley

    Nabil E. Omar

  19. Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review

    Article • Clinical Case Reports, January 2021, Wiley

    Nabil E. Omar

  20. Sickle Cell Anemia Presenting with Vaso-Occlusive Pain: Should We Screen for COVID-19?

    Article • Dubai Medical Journal, January 2021, Karger Publishers

    Nabil E. Omar

  21. Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents

    Article • Medicine, December 2020, Wolters Kluwer Health

    Nabil E. Omar

  22. Non-Epithelial Ovarian Cancer, an Experience From Qatar

    Article • November 2020, Research Square

    Nabil E. Omar

  23. Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review

    Article • Frontiers in Immunology, October 2020, Frontiers

    Nabil E. Omar, Dr Dina Johar, Dr Shereen Amin Elazzazy

  24. Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review

    Article • Medical Oncology, October 2020, Springer Science + Business Media

    Nabil E. Omar, Dr Shereen Amin Elazzazy

  25. Treatment of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: Protocol for a systematic review and meta-analysis

    Article • August 2020, Research Square

    Nabil E. Omar

  26. Tuberculosis Following PD-1 Inhibitor in A Patient with Non-Small Cell Lung Cancer; A Case Report & Literature Review

    Article • May 2020, MDPI AG

    Nabil E. Omar

  27. Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar

    Article • Journal of Oncology Pharmacy Practice, November 2019, SAGE Publications

    Dr Shereen Amin Elazzazy , Nabil E. Omar

  28. Pancytopenia And Limbic Encephalopathy Complicating Immunotherapy For Clear Cell Endometrial Cancer With Microsatellite Instability-High (MSI-H)

    Article • OncoTargets and Therapy, November 2019, Taylor & Francis

    Dr salha sb Bujassoum Al Bader , Nabil E. Omar

  29. 252PUterine sarcomas in Qatar: Clinico-pathological characteristics and treatment outcome

    Article • Annals of Oncology, November 2019, Oxford University Press (OUP)

    Nabil E. Omar

  30. Diabetes-induced Proteome Changes Throughout Development

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, September 2019, Bentham Science Publishers

    Dr Dina Johar, Rasha Azouz, Nabil E. Omar

  31. Perceptions and expectations of health care providers towards clinical pharmacy services in a mental health hospital in Qatar

    Article • Asian Journal of Psychiatry, April 2019, Elsevier

    Nabil E. Omar

  32. CLO19-045: Safety of Immune Checkpoint Inhibitors in Cancer Patients With Microsatellite Instability-High (MSI-H) Status: An Experience From Qatar

    Article • Journal of the National Comprehensive Cancer Network, March 2019, Harborside Press, LLC

    Nabil E. Omar

  33. Cutoff point for standard tube agglutination test in the diagnosis of human brucellosis in Egypt

    Article • Journal of Advanced Research, March 2019, Elsevier

    Nabil E. Omar

  34. Oncotype DX RS correlation with clinicopathologic risk factors and chemotherapy. Retrospective study in early stage ER positive breast cancer

    Article • Annals of Breast Cancer, November 2018, MedDocs Publishers LLC

    Nabil E. Omar

  35. Outcomes of patient education practices to optimize the safe use of lithium: A literature review

    Article • Mental Health Clinician, January 2018, College of Psychiatric and Neurologic Pharmacists (CPNP)

    Nabil E. Omar

  36. Pulmonary Hypertension Induced by Thalidomide (and Derivatives) in Patients with Multiple Myeloma: A Systematic Review

    Article • Journal of Cancer Therapy, January 2016, Scientific Research Publishing, Inc,

    Mr. Abdulqadir J Nashwan, Nabil E. Omar